VC  Red Abbey Venture Partners

http://www.redabbey.com/ravp.htm





     Office Locations:

10751 Falls Road, Suite 300
Baltimore, MD 21093
Phone: 410-494-4230

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Red Abbey Venture Partners was founded in 2004 and has invested in 15 privately-held and nine publicly-traded life science companies. Red Abbey Venture Partners is the second generation of a life sciences investment program that Frank A. Bonsal, Jr. and Philip Goelet, PhD began in 1997 with an investment in RiboTargets Holdings. The Partnership's primary investment objective is to generate superior, risk-adjusted returns by investing in high-quality life sciences companies that are developing novel therapeutics and other products based on distinctive technologies. The firm expects to capitalize on the advances in molecular biology, drug discovery and medical treatment that have permanently changed the treatment and management of disease. Red Abbey has a select group of family offices and individual investors who have committed $50 million to its fund.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Frank A. Bonsal Founding Member and Investment Committee
    Matt Zuga Investment Committee
    Philip Goelet PhD Founding Member and Investment Committee

     

    Portfolio companies include:


      Advanced Biohealing
        web link


      Aegerion Pharmaceuticals
        web link


      Alba Therapeutics
        web link


      Anacor Pharmaceuticals
        web link


      Arginetix
        web link


      CoGenesys
        web link


      Concentric Medical
        web link


      Corridor Pharmaceuticals
        web link


      Cyclacel Pharmaceuticals
        web link


      Cytokinetics
        web link


      Dynavax Technologies
        web link


      Favrille
        web link


      Inhibitex
        web link


      Insulet
        web link


      Iomai
        web link


      Kemia
        web link


      MacroGenics
        web link


      Metabasis Therapeutics
        web link


      Nereus Pharmaceuticals
        web link


      NicOx
        web link


      Oxagen
        web link


      Santarus
        web link


     

    Recent News:


      There is no recent news for Red Abbey Venture Partners.